Shin E[au] - Search Results

Year	Number of Results
1953	2
1961	1
1975	2
1976	1
1978	2
1984	1
1988	3
1990	2
1991	2
1992	6
1993	8
1994	10
1995	6
1996	6
1997	11
1998	10
1999	18
2000	28
2001	35
2002	30
2003	32
2004	52
2005	67
2006	67
2007	90
2008	83
2009	106
2010	102
2011	123
2012	112
2013	122
2014	140
2015	134
2016	172
2017	185
2018	213
2019	217
2020	208
2021	197
2022	9

1

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.

Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Park SH, Choi JY, Kim SH, Jung I, Shin EC. Lee JS, et al. Among authors: shin ec. Sci Immunol. 2020 Jul 10;5(49):eabd1554. doi: 10.1126/sciimmunol.abd1554. Sci Immunol. 2020. PMID: 32651212 Free PMC article.

2

Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.

Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group. Jeger RV, et al. Among authors: shin es. JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27. JACC Cardiovasc Interv. 2020. PMID: 32473887 Free article. Review.

3

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma.

Kim CG, Kim C, Yoon SE, Kim KH, Choi SJ, Kang B, Kim HR, Park SH, Shin EC, Kim YY, Kim DJ, Chung HC, Chon HJ, Choi HJ, Lim HY. Kim CG, et al. Among authors: shin ec. J Hepatol. 2021 Feb;74(2):350-359. doi: 10.1016/j.jhep.2020.08.010. Epub 2020 Aug 15. J Hepatol. 2021. PMID: 32810553

4

PD-1-Expressing SARS-CoV-2-Specific CD8⁺ T Cells Are Not Exhausted, but Functional in Patients with COVID-19.

Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, Sa M, Kim AR, Joo EJ, Ahn JY, Kim JH, Song KH, Kim ES, Oh DH, Ahn MY, Choi HK, Jeon JH, Choi JP, Kim HB, Kim YK, Park SH, Choi WS, Choi JY, Peck KR, Shin EC. Rha MS, et al. Among authors: shin ec. Immunity. 2021 Jan 12;54(1):44-52.e3. doi: 10.1016/j.immuni.2020.12.002. Epub 2020 Dec 14. Immunity. 2021. PMID: 33338412 Free PMC article.

5

Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality.

Choi H, Kim Y, Mirzaaghasi A, Heo J, Kim YN, Shin JH, Kim S, Kim NH, Cho ES, In Yook J, Yoo TH, Song E, Kim P, Shin EC, Chung K, Choi K, Choi C. Choi H, et al. Among authors: shin ec. Sci Adv. 2020 Apr 8;6(15):eaaz6980. doi: 10.1126/sciadv.aaz6980. eCollection 2020 Apr. Sci Adv. 2020. PMID: 32285005 Free PMC article.

6

Single-cell RNA sequencing identifies shared differentiation paths of mouse thymic innate T cells.

Lee M, Lee E, Han SK, Choi YH, Kwon DI, Choi H, Lee K, Park ES, Rha MS, Joo DJ, Shin EC, Kim S, Kim JK, Lee YJ. Lee M, et al. Among authors: shin ec. Nat Commun. 2020 Aug 31;11(1):4367. doi: 10.1038/s41467-020-18155-8. Nat Commun. 2020. PMID: 32868763 Free PMC article.

7

The type I interferon response in COVID-19: implications for treatment.

Lee JS, Shin EC. Lee JS, et al. Among authors: shin ec. Nat Rev Immunol. 2020 Oct;20(10):585-586. doi: 10.1038/s41577-020-00429-3. Nat Rev Immunol. 2020. PMID: 32788708 No abstract available.

8

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer.

Kim CG, Kim KH, Pyo KH, Xin CF, Hong MH, Ahn BC, Kim Y, Choi SJ, Yoon HI, Lee JG, Lee CY, Park SY, Park SH, Cho BC, Shim HS, Shin EC, Kim HR. Kim CG, et al. Among authors: shin ec. Ann Oncol. 2019 Jul 1;30(7):1104-1113. doi: 10.1093/annonc/mdz123. Ann Oncol. 2019. PMID: 30977778 Free article.

9

VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers.

Kim CG, Jang M, Kim Y, Leem G, Kim KH, Lee H, Kim TS, Choi SJ, Kim HD, Han JW, Kwon M, Kim JH, Lee AJ, Nam SK, Bae SJ, Lee SB, Shin SJ, Park SH, Ahn JB, Jung I, Lee KY, Park SH, Kim H, Min BS, Shin EC. Kim CG, et al. Among authors: shin ec. Sci Immunol. 2019 Nov 8;4(41):eaay0555. doi: 10.1126/sciimmunol.aay0555. Sci Immunol. 2019. PMID: 31704735

10

TOX-expressing terminally exhausted tumor-infiltrating CD8⁺ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.

Han HS, Jeong S, Kim H, Kim HD, Kim AR, Kwon M, Park SH, Woo CG, Kim HK, Lee KH, Seo SP, Kang HW, Kim WT, Kim WJ, Yun SJ, Shin EC. Han HS, et al. Among authors: shin ec. Cancer Lett. 2021 Feb 28;499:137-147. doi: 10.1016/j.canlet.2020.11.035. Epub 2020 Nov 27. Cancer Lett. 2021. PMID: 33249194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results